DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20162966

Male breast cancer with neurofibromatosis- a rare presentation

Pravin Balakrishna Bijwe, Vasant N. Lawankar, Pritam Murlidhar Deokar

Abstract


Neurofibromatosis (NF-1) was formerly known as Von Recklinghausen’s disease after the researcher (Friedrich Daniel Von Recklinghausen) who first documented the disorder. Patient with Neurofibromatosis type 1 have a higher risk of developing various type of cancers, especially tumors derived from embryo genic neural crest.


Keywords


Neurofibromatosis, CA breast, Epithelial malignancy, Mastectomy

Full Text:

PDF

References


Costa RM, Silva AJ. “Molecular and cellular mechanisms underlying the cognitive deficits associated with neurofibromatosis 1. Journal of child neurology. 2002;17(8):622-6.

Gokalp G, Hakyemez B. Myxoid neurofibromas of the breast : mammographical , sonological and MRI appearances. Br J Radiol. 2007;80:234-7.

Ricardi VM. Neurofibromatosids, phenotype, natural history and pathogenesis. Baltimore:John Hopkins University Press. 1992;305;1617-27.

Perry A, Roth KA, Benerjee R, Fuller CE, Gutman DH. NF 1 deletions in s-100 protein Positive and negative cells of sporadic and neurofibromatosis 1 (NF1) associated plexiform neurofibromas and peripheral nerve sheath tumors. Am J pathol. 2001:159:57-61.

Wallace MD, Pfefferle AD, Shen L, McNairn AJ, Cerami EG, Fallon BL, et al. Comparative Oncogenomics Implicates the Neurofibromin 1 Gene (NF1) as a Breast Cancer Driver. Genetics. 2012;192:385-396.

Friedman JM. Epidemiology of neurofibromatosis type 1. Am J Med Genet. 1999;89(1):1-6.

Xu GF, O’Connel P, Viskochil D, Cawthon R, Robertson M, Culver M, et al. The neuro-fibromatosis type 1 gene encodes a protein related to GAP. Cell. 1990;62:599-608.

Seminog OO, Golacare MJ. Risk of benign tumors of nervous system and of malignant Neoplasms, in people with neurofibromatosis: population- based record – linkage study. Br J Cancer. 2012. doi:10.1038/bjc.2012.535.

Nakamura M, Tangoku A, Kusangi H, Oka M, Suzuki T. Breast cancer associated with Recklinghausen’s disease : report of a case. Nippon Geka Hokan. 1998;67:3-9.

Wallace MD , Pfefferle AD , Shen L, McNairn AJ, Cerami EG, Fallon BL, etal. Comaparative oncogenomics implicates the neurofibromin 1 gene (NF1) as a breast cancer driver. Genetics. 2012;192:385-96.

Gurana S, Safali M. A case of neurofibromatosis and breast cancer: loss of hetrozygosity of NF 1 in breast cancer. Cancer Genet Cytogenet. 2005;156:86-8.

RD B, Das Gupta TK. Von Recklinghausen’s Disease : A Clinicopathological Study. Ann Surg Jan. 1972;175-1.

Murayama Y, Yamamaoto Y, Shimojima N, Takahara T, Kikuchi K, Iida S, et al. T1 breast cancer associated with Von Recklinghausen’s neurofibromatosis. Breast Cancer. 1999;6:227.

Sharif S, Moran A, Huson SM, Iddenden R, Shenton A, Howard E, Etal. Women with Neurofibromatosis are at a moderately increased risk of developing breast cancer and should be considered for early screening. J Med Genet. 2007;481-4.

Senkus E, Kyriakides S, Penault–Llorca F, Poortmans P, Thompson A, Zackrisson S, et al. Primary breast cancer : ESMO Clinical Practise Guidelines for diagnosis, treatment and follow –up. Ann Oncol. 2015;26(suppl 5):v8-v30.

Theriault RL, Carlson RW, Allred C, Giordano SH, Fred Hutchinson BO, Burstein HJ et al. NCCN Clinical Practise Guidelines in Oncology. J Natl Compr Canc Netw. 2013;11(7):753-60;quiz 761.

Yamamoto Y, Kanazawa H, Sughara T. Breast reconstruction in the Von Recklinghausen disease patient. Plastic Reconstr Surg. 2002;110:357.